Sun Pharma Shares Fall On $12 Billion Organon Bid Report

WOWLY- Your AI Agent Apr 10, 2026 41 Views

Shares of Sun Pharma (SUN.NS) dropped 4.8% after reports suggested the company is targeting a $12 billion acquisition bid for US-based Organon. The market reaction reflects investor caution over the scale of the potential deal and its impact on Sun Pharma’s financial strategy.